title: Epigenetic regulation of Elf5 is associated with epithelial-mesenchymal transition in urothelial cancer.
abstract: E74-like factor 5 (Elf5) has been associated with tumor suppression in breast cancer. However, its role in urothelial cancer (UC) is completely unknown. Immunohistochemistry (IHC) and methylation specific PCR (MSP) were done to detect Elf5 expression level and its promoter methylation. Results revealed that low expression of Elf5 on protein and mRNA levels were associated with tumor progression, early relapse and poor survival. In vitro, down-regulation of Elf5 can increase epithelial-mesenchymal transition (EMT). Aberrant Elf5 methylation was identified as major mechanism for Elf5 gene silence. Accordingly, restoration of Elf5 by infection or demethylating treatment effectively reversed EMT processes. In conclusion, we identified Elf5 as a novel biomarker of UC on several biological levels and established a causative link between Elf5 and EMT in UC.
authors: Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China.
authors: Bo
authors: B
authors: Wu
authors: Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China.
authors: Xiaoming
authors: X
authors: Cao
authors: Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China.
authors: Xuezhi
authors: X
authors: Liang
authors: First Clinical Medical College, Shanxi Medical University, Taiyuan, China.
authors: Xuhui
authors: X
authors: Zhang
authors: Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China.
authors: Wei
authors: W
authors: Zhang
authors: Department of Urology, Second Hospital of Tianjin Medical University, Tianjin, China.
authors: Guang
authors: G
authors: Sun
authors: Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China; First Clinical Medical College, Shanxi Medical University, Taiyuan, China.
authors: Dongwen
authors: D
authors: Wang
mesh_terms: D014408:Biomarkers, Tumor; D045744:Cell Line, Tumor; D019175:DNA Methylation; D004268:DNA-Binding Proteins; D044127:Epigenesis, Genetic; D058750:Epithelial-Mesenchymal Transition / Q000235:genetics*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008875:Middle Aged; D011401:Promoter Regions, Genetic; D050783:Proto-Oncogene Proteins c-ets / Q000235:genetics*; D014157:Transcription Factors; D014571:Urologic Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D019459:Urothelium / Q000378:metabolism / Q000473:pathology*
chemical_list: D014408:Biomarkers, Tumor; D004268:DNA-Binding Proteins; C116038:ELF5 protein, human; D050783:Proto-Oncogene Proteins c-ets; D014157:Transcription Factors
references: Bioinformatics. 2002 Nov;18(11):1427-31
references: 12424112
references: Urol Clin North Am. 2003 Nov;30(4):765-76
references: 14680313
references: Nat Rev Cancer. 2005 Sep;5(9):713-25
references: 16110317
references: Oncogene. 2008 Jan 31;27(6):865-76
references: 17653090
references: Dev Cell. 2008 Jun;14(6):818-29
references: 18539112
references: Nat Cell Biol. 2008 Nov;10(11):1280-90
references: 18836439
references: BMC Genomics. 2008 Dec 08;9:591
references: 19063729
references: Nat Rev Cancer. 2009 Apr;9(4):265-73
references: 19262571
references: J Clin Invest. 2009 Jun;119(6):1438-49
references: 19487820
references: Funct Integr Genomics. 2010 Mar;10(1):87-95
references: 19830464
references: Cell. 2009 Nov 25;139(5):871-90
references: 19945376
references: Biomark Med. 2009 Jun 1;3(3):265
references: 20161673
references: Hum Mol Genet. 2010 Jun 15;19(12):2456-67
references: 20354077
references: Mol Endocrinol. 2010 Jul;24(7):1380-92
references: 20519331
references: Oncogene. 2010 Aug 26;29(34):4741-51
references: 20531305
references: BMC Mol Biol. 2010 Sep 10;11:68
references: 20831799
references: Cell. 2011 Jun 10;145(6):926-40
references: 21663795
references: Stem Cells. 2011 Oct;29(10):1611-9
references: 21823211
references: Stem Cells. 2012 Jul;30(7):1496-508
references: 22523003
references: Exp Cell Res. 2013 Jan 15;319(2):160-9
references: 22935683
references: J Biol Chem. 2012 Nov 16;287(47):39954-66
references: 23012352
references: Nat Cell Biol. 2012 Nov;14(11):1212-22
references: 23086238
references: PLoS Biol. 2012;10(12):e1001461
references: 23300383
references: Cancer Lett. 2013 Nov 28;341(1):80-96
references: 23376253
references: J Urol. 2014 Feb;191(2):493-501
references: 24018236
references: Nat Med. 2013 Nov;19(11):1438-49
references: 24202396
references: CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29
references: 24399786
references: Cancer Res. 2014 May 15;74(10):2750-62
references: 24638979
references: J Urol. 1988 Feb;139(2):283-5
references: 3339726